Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2001;32:1336-1340

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tejima, E.
Right arrow Articles by Lo, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tejima, E.
Right arrow Articles by Lo, E. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
*Stroke
Hazardous Substances DB
*HYDRALAZINE HYDROCHLORIDE
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction
Right arrow Embolic stroke
Right arrow Thrombolysis

(Stroke. 2001;32:1336.)
© 2001 American Heart Association, Inc.


Original Contributions

Hemorrhagic Transformation After Fibrinolysis With Tissue Plasminogen Activator

Evaluation of Role of Hypertension With Rat Thromboembolic Stroke Model

Emiri Tejima, MD; Yoichi Katayama, MD, PhD; Yasuyuki Suzuki, MD; Tsuneo Kano, MD, PhD Eng H. Lo, PhD

From the Department of Neurological Surgery (E.T., Y.K., Y.S., T.K.), Nihon University School of Medicine, Tokyo, Japan, and the Neuroprotection Research Laboratory (E.H.L.), Departments of Neurology and Radiology, Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Boston, Mass.

Correspondence to Dr Tsuneo Kano, 30-1 Oyaguchi Kamimachi, Itabashi-ku, Tokyo 173-8610, Japan. E-mail tsuneok{at}med.nihon-u.ac.jp

Background and Purpose—We used a rat model of thromboembolic stroke to evaluate whether hypertension increases the incidence of hemorrhage after fibrinolysis with tissue plasminogen activator (tPA).

Methods—In this model, a microclot suspension was injected into the middle cerebral artery territory to induce focal ischemia. Reperfusion was induced in spontaneously hypertensive rats (SHR) by administering tPA (10 mg/kg) intravenously at 2 hours or 6 hours after the onset of thromboembolic focal ischemia. In untreated control rats, saline was administered at 2 hours after ischemia.

Results—Hemorrhagic transformation was observed only in rats that received tPA at 6 hours (6 of 8 rats [75%]). Reduction of mean arterial blood pressure from 122±3 to 99±2 mm Hg with hydralazine, given to SHR for 1 week before ischemia, significantly decreased the incidence of hemorrhage in 2 of 11 rats (18%). tPA reduced infarct volumes, but cotreatment with hydralazine did not result in further protection.

Conclusions—This study demonstrates that in this rat thromboembolic model of stroke, tPA-induced hemorrhage is dependent on blood pressure and that pharmacological reduction of hypertension during fibrinolysis can reduce the risk of hemorrhagic transformation.


Key Words: cerebral hemorrhage • fibrinolysis • hypertension • stroke • rats




This article has been cited by other articles:


Home page
StrokeHome page
Y. Loh, A. Towfighi, D. S. Liebeskind, D. L. MacArthur, P. Vespa, N. R. Gonzalez, S. Tateshima, S. Starkman, J. L. Saver, Z.-S. Shi, et al.
Basal Ganglionic Infarction Before Mechanical Thrombectomy Predicts Poor Outcome
Stroke, October 1, 2009; 40(10): 3315 - 3320.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Kuroiwa, G. Xi, Y. Hua, T. N. Nagaraja, J. D. Fenstermacher, and R. F. Keep
Development of a Rat Model of Photothrombotic Ischemia and Infarction Within the Caudoputamen
Stroke, January 1, 2009; 40(1): 248 - 253.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Saguchi, H. Onoue, M. Urashima, T. Ishibashi, T. Abe, and H. Furuhata
Effective and Safe Conditions of Low-Frequency Transcranial Ultrasonic Thrombolysis for Acute Ischemic Stroke: Neurologic and Histologic Evaluation in a Rat Middle Cerebral Artery Stroke Model
Stroke, March 1, 2008; 39(3): 1007 - 1011.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Gautier, O. Petrault, P. Gele, M. Laprais, M. Bastide, A. Bauters, D. Deplanque, B. Jude, J. Caron, and R. Bordet
Involvement of Thrombolysis in Recombinant Tissue Plasminogen Activator-Induced Cerebral Hemorrhages and Effect on Infarct Volume and Postischemic Endothelial Function
Stroke, December 1, 2003; 34(12): 2975 - 2979.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Castellanos, R. Leira, J. Serena, J. M. Pumar, I. Lizasoain, J. Castillo, A. Davalos, and G. F. Hamann
Plasma Metalloproteinase-9 Concentration Predicts Hemorrhagic Transformation in Acute Ischemic Stroke * Editorial Comment
Stroke, January 1, 2003; 34(1): 40 - 46.
[Abstract] [Full Text] [PDF]